Literature DB >> 30793688

Abnormal B-Cell Subset and Blimp-1-Mediated Humoral Responses Associated With Visceral Leishmaniasis Pathogenesis.

Bhawana Singh1, Om Prakash Singh1, Neetu Singh1, Siddharth Sankar Singh1, Shyam Sundar1.   

Abstract

B-cells have a spectrum of functions ranging from antibody production to antigen presentation and have additional vital roles in immune mechanisms. There is rudimentary knowledge about the role of B-cells in intracellular infections with contradictory findings. We explored the role of B-cell dysfunctions in visceral leishmaniasis (VL) pathogenesis in terms of the phenotypic and functional properties of B-cells during the course of disease. This study was performed on blood and splenic aspirates (SA) of VL cases pre- and post-treatment. Whole blood was used for flow cytometric studies for determining the profiles of B-cells at different time-points of treatment. Peripheral blood mononuclear cells were used for magnetic purification of B-cells, for transcriptional studies by real-time polymerase chain reaction (RT-PCR). Serum/plasma was used for direct agglutination test for determining parasite-specific antibodies and SA were used for scoring the presence of parasite by microscopic examination. Flow cytometric studies depicted decreased B-cell percentages during the entire course of disease and attainment of exhaustive phenotype with tissue-like memory cell markers, indicative of B-cell dysfunctions in VL. In addition, B-cells had compromised abilities of antigen processing and presentation and altered levels of B-lymphocyte-induced maturation protein-1 (Blimp-1). Blimp-1 expression goes hand in hand with B-cell maturation antigen and transmembrane activator and calcium modulator (TACI) and cyclophilin ligand interactor, suggestive of its role in promoting plasma cell survival and antibody production. Elevated level of VL-specific antibody titre was directly correlated with exhausted phenotype and also with disease severity during VL. This study indicated for impaired B-cell functions during chronic infection which may lead to pathological consequences in human VL.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30793688      PMCID: PMC6447117          DOI: 10.4269/ajtmh.18-0350

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  29 in total

1.  BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells.

Authors:  J F Piskurich; K I Lin; Y Lin; Y Wang; J P Ting; K Calame
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

2.  Improvement of a direct agglutination test for field studies of visceral leishmaniasis.

Authors:  A el Harith; A H Kolk; J Leeuwenburg; R Muigai; E Huigen; T Jelsma; P A Kager
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

3.  Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation.

Authors:  Eszter Deak; Asha Jayakumar; Ka Wing Cho; Karen Goldsmith-Pestana; Blaise Dondji; John D Lambris; Diane McMahon-Pratt
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

4.  IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro.

Authors:  Jean-David Bouaziz; Sebastien Calbo; Maud Maho-Vaillant; Anne Saussine; Martine Bagot; Armand Bensussan; Philippe Musette
Journal:  Eur J Immunol       Date:  2010-10       Impact factor: 5.532

5.  Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection.

Authors:  Nanchaya Wanasen; Lijun Xin; Lynn Soong
Journal:  Int J Parasitol       Date:  2007-09-20       Impact factor: 3.981

6.  B-cell maturation antigen is a promising target for adoptive T-cell therapy of multiple myeloma.

Authors:  Robert O Carpenter; Moses O Evbuomwan; Stefania Pittaluga; Jeremy J Rose; Mark Raffeld; Shicheng Yang; Ronald E Gress; Frances T Hakim; James N Kochenderfer
Journal:  Clin Cancer Res       Date:  2013-01-23       Impact factor: 12.531

7.  Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation.

Authors:  Martina Minnich; Hiromi Tagoh; Peter Bönelt; Elin Axelsson; Maria Fischer; Beatriz Cebolla; Alexander Tarakhovsky; Stephen L Nutt; Markus Jaritz; Meinrad Busslinger
Journal:  Nat Immunol       Date:  2016-01-18       Impact factor: 25.606

8.  Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA.

Authors:  P Silacci; A Mottet; V Steimle; W Reith; B Mach
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

9.  Malaria-associated atypical memory B cells exhibit markedly reduced B cell receptor signaling and effector function.

Authors:  Silvia Portugal; Christopher M Tipton; Haewon Sohn; Younoussou Kone; Jing Wang; Shanping Li; Jeff Skinner; Kimmo Virtaneva; Daniel E Sturdevant; Stephen F Porcella; Ogobara K Doumbo; Safiatou Doumbo; Kassoum Kayentao; Aissata Ongoiba; Boubacar Traore; Inaki Sanz; Susan K Pierce; Peter D Crompton
Journal:  Elife       Date:  2015-05-08       Impact factor: 8.140

10.  Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals.

Authors:  Susan Moir; Jason Ho; Angela Malaspina; Wei Wang; Angela C DiPoto; Marie A O'Shea; Gregg Roby; Shyam Kottilil; James Arthos; Michael A Proschan; Tae-Wook Chun; Anthony S Fauci
Journal:  J Exp Med       Date:  2008-07-14       Impact factor: 14.307

View more
  2 in total

1.  Chromatin-Remodeling Factor BRG1 Is a Negative Modulator of L. donovani in IFNγ Stimulated and Infected THP-1 Cells.

Authors:  Harsimran Kaur Brar; Gargi Roy; Akanksha Kanojia; Evanka Madan; Rentala Madhubala; Rohini Muthuswami
Journal:  Front Cell Infect Microbiol       Date:  2022-04-01       Impact factor: 6.073

2.  Modulation of Host Immune Response during Leishmania infantum Natural Infection: A Whole-Transcriptome Analysis of the Popliteal Lymph Nodes in Dogs.

Authors:  Carolina R Sanz; Guadalupe Miró; Natalia Sevane; Armando Reyes-Palomares; Susana Dunner
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.